House Judiciary Committee Investigates Pfizer COVID Vaccine Timing Allegations

The House Judiciary Committee is investigating allegations that Pfizer deliberately delayed the release of successful COVID-19 vaccine trial results until after the 2020 presidential election, based on claims by former Pfizer scientist Philip Dormitzer. Dormitzer, now with GSK, allegedly stated that senior Pfizer research personnel were involved in this decision, although he later denied these claims, asserting his comments were misinterpreted. The committee has requested documents and an interview from Dormitzer and Pfizer to clarify the timing and transparency of the vaccine data dissemination. Pfizer has denied any wrongdoing, maintaining that all actions complied with FDA guidelines. Despite the ongoing investigation, Pfizer's stock currently holds a "Hold" rating from analysts, with an average price target suggesting potential upside. The inquiry reflects broader concerns about the intersection of pharmaceutical data release and political events during the pandemic.